As the delta variant of the coronavirus tears through the US, pushing both new and breakthrough infections higher, the US Centers for Disease Control (CDC) has now come...
US biotech Amgen is planning to spend $550 million on building a new biologics manufacturing plant in Holly Springs, Wake County in North Carolina. Construction is...
As it continues to grapple with documentation issues, US biotech Novavax has again altered its timeline for seeking Emergency Use Authorization (EUA) from the US Food and...
US biotech Regeneron is planning to invest roughly $1.8 billion over six years to expand its research, preclinical manufacturing and support facilities at its Westchester...
For an undisclosed sum, Germany’s Evonik has acquired German industrial biotech JeNaCell, thereby expanding its biomaterials portfolio to biotechnologically derived...
In a deal potentially worth $2 billion, German drugs and agriculture company Bayer is acquiring Vividion Therapeutics, a San Diego-based US biotech. The California...
The European Commission has finalized an advance purchase agreement with Novavax covering 100 million doses of the US biotech’s protein-based Covid-19 vaccine initially...
French drugmaker Sanofi has signed a definitive agreement to acquire Translate Bio, the clinical-stage mRNA therapeutics company with which it is currently cooperating on...
US CDMO Curia, formerly AMRI, has agreed to acquire LakePharma, a privately held biologics drug discovery, clinical research, development and manufacturing organization...
BioNTech has launched a new project aimed at developing what it hopes will be a well-tolerated and highly effective malaria vaccine for the African continent. The Mainz...
